Agenus, Inc. (AGEN)
3.14
0.00 (0.00%)
USD |
NASDAQ |
Jun 09, 12:50
Agenus SG&A Expense (Quarterly) : 6.86M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Iovance Biotherapeutics, Inc. | 38.95M |
| AnaptysBio, Inc. | 26.20M |
| Amarin Corp. Plc | 19.35M |
| Inovio Pharmaceuticals, Inc. | 7.880M |
| Vertex Pharmaceuticals, Inc. | 493.70M |